Partner
Maxime Colle
Corporate and M&A
Insolvency and Restructuring
Private Equity & Venture Capital
Telecommunications, Media & Technology
maxime.colle@lydian.be
Lydian successfully assisted Eli Lilly in its investment in Augustine Therapeutics NV
We are thrilled to announce that Lydian assisted Eli Lilly in its investment in Augustine Therapeutics NV during their Series A financing round.
Augustine Therapeutics, a Leuven-based biotech company, raised €17 million to advance its leading candidate treatment for neurological disorders.
The Lydian team was led by Maxime Colle and included Louise Berrier and Maxine Daems.
Read more about this exciting development in De Tijd.
#Biotech #Lydian #VentureCapital #MergersAndAcquisitions
Authors
-
Download VCARD
-
-
